Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction

J Infect Dis. 2012 May 1;205(9):1417-24. doi: 10.1093/infdis/jis208. Epub 2012 Mar 29.

Abstract

In leprosy, type 1 reaction (T1R) and type 2 reaction (T2R) are major causes of nerve injury and permanent disabilities. A previous study on plasma levels of 27 cytokines in patients with T1R or T2R and controls with nonreactional leprosy identified the gene for interleukin 6 (IL-6) as a candidate for genetic analysis. Two nested case-control studies were built from a cohort of 409 patients with leprosy from central Brazil, monitored for T1R and T2R. There was evidence for association between T2R and IL-6 tag single-nucleotide polymorphisms rs2069832 (P = .002), rs2069840 (P = .03), and rs2069845 (P = .04), with information on the entire IL-6 locus, as well as functional IL-6 variant rs1800795 (P = .005). Moreover, IL-6 plasma levels in patients with T2R correlated with IL-6 genotypes (P = .04). No association was found between IL-6 variants and T1R. Identifying genetic predictive factors for leprosy reactions may have a major impact on preventive strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Brazil
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Genetic Loci
  • Genetic Markers
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Interleukin-6 / genetics*
  • Leprosy / diagnosis
  • Leprosy / genetics*
  • Leprosy / immunology
  • Leprosy / physiopathology
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Polymorphism, Single Nucleotide
  • Prospective Studies
  • Selection, Genetic
  • Young Adult

Substances

  • Genetic Markers
  • IL6 protein, human
  • Interleukin-6